We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.08B
1-Year Est. Return 25.65%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+25.65%
3 Year Est. Return
+74.65%
5 Year Est. Return
+97.11%
10 Year Est. Return
+319.6%
AUM
$1.51B
AUM Growth
+$9.99M
Cap. Flow
-$12.7M
Cap. Flow %
-0.84%
Top 10 Hldgs %
19.92%
Holding
1,417
New
217
Increased
264
Reduced
441
Closed
109

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$5.65M
2
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$4.05M
3
JPM icon
JPMorgan Chase
JPM
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.41M
5
CB icon
Chubb
CB
+$1.22M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$2.97M
2
VZ icon
Verizon
VZ
+$2.06M
3
WFC icon
Wells Fargo
WFC
+$1.89M
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$1.76M
5
TIP icon
iShares TIPS Bond ETF
TIP
+$1.73M

Sector Composition

Rank Sector Weight
1 Healthcare 12.62%
2 Industrials 12.48%
3 Technology 11.81%
4 Consumer Staples 11.77%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FITB
576
Fifth Third Bancorp
FITB
$51.7B
$85K 0.01%
3,270
-234
-7% -$5.78K
JAZZ icon
577
Jazz Pharmaceuticals
JAZZ
$16B
$85K 0.01%
550
-60
-10% -$9.18K
ULTA icon
578
Ulta Beauty
ULTA
$20.7B
$85K 0.01%
296
– –
LNT icon
579
Alliant Energy
LNT
$19.1B
$84K 0.01%
2,080
+600
+41% +$24.3K
WPZ
580
DELISTED
Williams Partners L.P.
WPZ
– –
0
– –
AZ
581
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$84K 0.01%
4,258
-2,238
-34% -$44.1K
IHE icon
582
iShares US Pharmaceuticals ETF
IHE
$1.48B
$83K 0.01%
1,605
– –
ISRG icon
583
Intuitive Surgical
ISRG
$128B
$83K 0.01%
801
+36
+5% +$3.46K
HOG icon
584
Harley-Davidson
HOG
$2.61B
$82K 0.01%
1,512
+160
+12% +$8.9K
M icon
585
Macy's
M
$6.57B
$82K 0.01%
3,498
-11,150
-76% -$286K
COHR
586
DELISTED
Coherent Inc
COHR
$82K 0.01%
365
– –
PGX icon
587
Invesco Preferred ETF
PGX
$3.81B
$80K 0.01%
5,305
+2,000
+61% +$30K
SEB icon
588
Seaboard Corp
SEB
$4.42B
$80K 0.01%
20
– –
TER icon
589
Teradyne
TER
$52.4B
$80K 0.01%
2,650
-300
-10% -$10.1K
DXCM icon
590
DexCom
DXCM
$28.3B
$79K 0.01%
4,300
+300
+8% +$5.54K
PNW icon
591
Pinnacle West Capital
PNW
$12.8B
$79K 0.01%
933
– –
ABB
592
DELISTED
ABB Ltd
ABB
$79K 0.01%
3,200
– –
PSXP
593
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
– –
0
– –
ENS icon
594
EnerSys
ENS
$6.94B
$78K 0.01%
1,081
+31
+3% +$2.44K
MHK icon
595
Mohawk Industries
MHK
$7.05B
$76K 0.01%
313
-1,430
-82% -$337K
TEP
596
DELISTED
Tallgrass Energy Partners, LP
TEP
– –
0
– –
HRB icon
597
H&R Block
HRB
$5.37B
$73K ﹤0.01%
2,353
– –
ORI icon
598
Old Republic International
ORI
$10.5B
$73K ﹤0.01%
3,735
+1,100
+42% +$21.9K
SUPN icon
599
Supernus Pharmaceuticals
SUPN
$2.73B
$73K ﹤0.01%
1,704
-151
-8% -$5.37K
URI icon
600
United Rentals
URI
$70.2B
$73K ﹤0.01%
642
+368
+134% +$41.1K
22 23
24
25 26

Similar funds

JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return

Central Trust Company's Q2 2017 Portfolio in Review

As of Q2 2017, Central Trust Company held 1,417 positions worth $1.51B, up 0.66% from $1.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Central Trust Company's Q2 2017 filing shows 217 new, 264 increased, 441 reduced and 109 closed positions. Its largest new stake was Abiomed Inc: 2,855 shares worth $409K. The largest sale was Xilinx Inc, an estimated $2.97M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Technology.

  • Central Trust Company's largest Q2 2017 buy was Abiomed Inc: 2,855 shares worth $409K.
  • Central Trust Company added most to iShares Gold Trust in Q2 2017, an estimated $5.65M increase.
  • Central Trust Company's biggest Q2 2017 reduction was Xilinx Inc, cutting an estimated $2.97M.
  • Central Trust Company fully exited Zayo Group Holdings, Inc. in Q2 2017, selling an estimated $91K.
  • Central Trust Company's ten largest holdings make up 20% of its $1.51B portfolio in Q2 2017.
  • Central Trust Company opened 217 new positions and closed 109 in Q2 2017.
  • Central Trust Company's portfolio value rose 0.66% quarter-over-quarter to $1.51B.

Based on Central Trust Company's 13F filing for Q2 2017, filed 14 Jul 2017.